The Scottish Medicines Consortium (SMC) has accepted fampridine (Fampyra) for MS patients. The medicine, produced by Biogen Inc, is available to people scoring 4-7 on the Expanded...
Around half of all people with MS have difficulties at some time with aspects of thinking such as memory, concentration or problem solving, known as cognitive...
Miles for MS is the MS Trust’s accessible distance challenge which takes place throughout May. Participants set their own distance challenge to complete over the course...
Ocrevus (ocrelizumab) has become the first treatment for primary proressive MS to be approved in Scotland – following its approval in England last year. The Scottish Medicines...
Siponimod, a tablet taken once daily to treat secondary progressive MS (SPMS), is currently under investigation by NICE to assess whether it should be available via...
The UK MS Register, based at Swansea University, was established in 2011 as the first nationwide register of its kind. It seeks to gather information from...
